Morgan Stanley’s Intercure INCR Stock Holding History

Morgan Stanley’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.49K	Buy	816 +10	+1%	+$44	﹤0.01%	7236
2026 Q1	$3.03K	Sell	806 -27	-3%	-$118	﹤0.01%	7248
2025 Q4	$3.79K	Buy	833 +28	+3%	+$195	﹤0.01%	7117
2025 Q3	$6.6K	Sell	805 -30	-4%	-$233	﹤0.01%	7017
2025 Q2	$6.14K	Buy	835 +29	+4%	+$214	﹤0.01%	6976
2025 Q1	$5.64K	Buy	806 +6	+0.8%	+$48	﹤0.01%	6959
2024 Q4	$6.36K	Hold	800	–	–	﹤0.01%	6941
2024 Q3	$8.04K	Hold	800	–	–	﹤0.01%	6781
2024 Q2	$8.04K	Hold	800	–	–	﹤0.01%	6738
2024 Q1	$10.8K	Hold	800	–	–	﹤0.01%	6676
2023 Q4	$5.16K	Sell	800 -120	-13%	-$732	﹤0.01%	6830
2023 Q3	$7.22K	Sell	920 -482	-34%	-$3.85K	﹤0.01%	6824
2023 Q2	$11.9K	Hold	1,402	–	–	﹤0.01%	6748
2023 Q1	$14.3K	Buy	1,402 +482	+52%	+$7.25K	﹤0.01%	6747
2022 Q4	$15.2K	Hold	920	–	–	﹤0.01%	6793
2022 Q3	$21K	Hold	920	–	–	﹤0.01%	6770
2022 Q2	$27K	Hold	920	–	–	﹤0.01%	6870
2022 Q1	$33K	Hold	920	–	–	﹤0.01%	6900
2021 Q4	$30K	Sell	920 -2	-0.2%	-$72	﹤0.01%	7045
2021 Q3	$32K	Buy	+922	New	+$33.1K	﹤0.01%	6904

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Quent Capital New York $1.63B AUM 27.42% 1-Year Est. Return

Morgan Stanley's INCR Position: Q2 2026 in Review

Morgan Stanley increased its Intercure (INCR) stake by 1.2% in Q2 2026, buying an estimated $44 and bringing the position to 816 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #7236.

Morgan Stanley first reported a position in INCR in Q3 2021 and has held it in 20 quarters since. The position peaked at $33K in Q1 2022. 16 funds tracked by Wall St. Rank hold INCR as of Q2 2026.

Morgan Stanley held 816 shares of Intercure worth $4.49K as of Q2 2026.
Morgan Stanley bought 10 Intercure shares in Q2 2026, an estimated $44.
Intercure made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7236 holding.
Morgan Stanley first reported a position in Intercure in Q3 2021 and has held it in 20 quarters since.
Morgan Stanley's Intercure position peaked at $33K in Q1 2022.
16 funds tracked by Wall St. Rank held Intercure as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.